Clinical Trials

Clinical Trials

Bimatoprost, the compound at the core of the Mylash service, has a lot of clinical evidence backing it and FDA approval. Below are links to clinical trials carried out independently from Mylash.

Steve Yoelin MD

“Bimatoprost was found safe for eyelid application and was associated with enhanced eyelash growth. All subjects noticed favorable changes in the appearance of their eyelashes.”

Link: http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4725.2010.01519.x/abstract

Joel Cohen MD. Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth. Dermatologic Surgery (2010), 36: 1361–1371

“By influencing the eyelash hair cycle and follicles, bimatoprost ophthalmic solution 0.03% is a safe and effective means of enhancing eyelash growth.”

Link: http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4725.2010.01522.x/abstract

Steven Fagien MD. Management of hypotrichosis of the eyelashes: Focus on bimatoprost. Clinical, Cosmetic and Investigational Dermatology (2010) :3 39–48.

“Taken together, available data suggest that cutaneous application of bimatoprost ophthalmic solution 0.03% safely and effectively enhances upper eyelash growth.”

Link: http://www.dovepress.com/getfile.php?fileID=6098

Zaheri et al. Successful use of bimatoprost in the treatment of alopecia of the eyelashes. Clinical and Experimental Dermatology (2010), 35: e161–e162.

Link: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2230.2009.03755.x/abstract

Dr Glaser, September 2012

Latisse shows long term success. Link:
http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Latisse-shows-long-term-success-according-to-recen/ArticleStandard/Article/detail/786585?contextCategoryId=40160&ref=25

Written by

Featured In:

Featured In: